Mercado mundial de derrame pleural: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado de derrame pleural

Se espera que el mercado mundial de derrame pleural experimente un crecimiento significativo durante el período de pronóstico mencionado. Los mercados en ascenso y la enorme inversión en I+D son los impulsores responsables del crecimiento de este mercado. La creciente prevalencia de enfermedades pulmonares en todo el mundo y los mercados emergentes son los factores responsables del crecimiento de este mercado. COVID-19 también tuvo un impacto importante en el crecimiento del mercado.

Data Bridge Market Research analiza la tasa de crecimiento del mercado mundial de derrame pleural en el período de pronóstico 2022-2029. La CAGR esperada del mercado mundial de derrame pleural tiende a rondar el 6% en el período de pronóstico mencionado. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado seleccionado por el equipo de Data Bridge Market Research también incluye un análisis profundo de expertos, epidemiología de los pacientes, análisis de la cartera de proyectos, análisis de precios y marco regulatorio.

Definición de mercado

El derrame pleural es una afección en la que se acumula líquido en las capas pleurales fuera de los pulmones. Por lo general, se necesita una pequeña cantidad de líquido para el movimiento de los pulmones y para la respiración normal. La presencia de afecciones específicas, como cirrosis hepática, embolia pulmonar, enfermedades renales y neumonía, aumenta el riesgo de derrame pleural. Además, el derrame pleural puede causar cáncer de pulmón en los hombres y cáncer de mama en las mujeres. Es de gran importancia para el sector sanitario y, por lo tanto, se espera que aumente en el período de pronóstico.

Alcance y segmentación del mercado de derrame pleural

Global Pleural Effusion Market Dynamics

Drivers

• Increase in Geriatric Population

The geriatric population is expected to increase the patient population globally, which boots the global hematuria treatment market in the forecast period. According to the WHO, the global elderly population is expected to reach around 2 billion by 2050, from 617 million in 2015. This boost the market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Increased Incidence of Pleural Effusion Disease

The incidence and prevalence of pleural effusions disease is growing fast globally. According to WHO, approximately one million pleural effusions cases are witnessed in the United States each year. Its incidence is increasing and its treatment is of great importance to the healthcare sector.

Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global pleural effusion market over a forecast period.

• High Cost

The huge expenditure of the treatment methods surely hamper the market growth.

This global pleural effusion market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pleural effusion market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Pleural Effusion Market Scope

The global pleural effusion market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Transudative
• Exudative
• Others

Treatment

• Surgery
• Medication
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Pleural Effusion Market Regional Analysis/Insights

The global pleural effusion market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global pleural effusion market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to increasing infection in geriatric population, and growing population with cardiovascular diseases.

Asia-Pacific dominates the market due to increased prevalence of lung infections and associated diseases and increasing initiatives taken by the government and pharmaceutical organizations to spread awareness.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Pleural Effusion Market Share Analysis

The global pleural effusion market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global pleural effusion market.

Key players operating in the global pleural effusion market include:

• Pfizer Inc (U.S.)
• F. Hoffmann-La Roche Ltd (Suiza)
• Mylan NV (Estados Unidos)
• Fresenius Kabi AG (Alemania)
• Hebei Changshan Biochemical Pharmaceutical Co. Ltd. (China)
• Hikma Pharmaceuticals PLC (Japón)
• Novartis AG (Estados Unidos)
• Shanghai Fosun Pharmaceutical (Grupo) Co., Ltd (China)
• Industrias farmacéuticas Teva Ltd. (Israel)
• HEYER Medical AG (Alemania)
• Biometrix (Países Bajos)
• Smiths Medical, Inc. (Estados Unidos)

SKU-53635